Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2026 | Adherence to weight loss intervention in breast cancer patients

Jennifer Ligibel, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the sustainability of adherence to a weight loss intervention in the BWEL trial (NCT02750826). A focus of the intervention was behavioral change, which helped maintain a consistent adherence to the program over time. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.